[Pulmonary strongyloidiasis complicated by E. coli meningitis in a HIV-1 and HTLV-1 positive patient].
BACKGROUND
Disseminated strongyloidiasis occurs in immunodepressed patients, notably those infected by retroviruses.


METHODS
A pulmonary strongyloidiasis, complicated by an Escherichia coli meningitis, occurred in a patient exhibiting seropositivity HIV1 for the past year. The status of cell immunity, with 354 lymphocytes T CD4+/mm3, could not explain this severe complication. This led to the diagnosis of an HTLV1 infection. The strongyloidiasis was treated with two cycles of ivermectine, which cured the patient.


CONCLUSIONS
In HIV-infected patients exhibiting severe strongyloidiasis, research for an HTLV co-infection is recommended.
Hovette
P
P
Service des Maladies Infectieuses et tropicales, Hôpital d'instruction des armées Laveran, 13998 Marseille Armées.
Tuan
J F
JF
Camara
P
P
Lejean
Y
Y
Lô
N
N
Colbacchini
P
P
D000969:Antinematodal Agents / Q000627:therapeutic use; D015658:HIV Infections / Q000150:complications*; D015497:HIV-1; D015490:HTLV-I Infections / Q000150:complications*; D006801:Humans; D016867:Immunocompromised Host; D007559:Ivermectin / Q000627:therapeutic use; D008171:Lung Diseases / Q000469:parasitology*; D008297:Male; D020814:Meningitis, Escherichia coli / Q000473:pathology* / Q000821:virology; D008875:Middle Aged; D011379:Prognosis; D013322:Strongyloidiasis / Q000150:complications* / Q000188:drug therapy
D000969:Antinematodal Agents; D007559:Ivermectin